19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Massimiliano Cazzaniga is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 29 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., Jan 1 2020, In : Breast Care. 15, p. 30-37 8 p.

Research output: Contribution to journalArticle

  • Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE

    Leo, S., Arnoldi, E., Repetto, L., Coccorullo, Z., Cinieri, S., Fedele, P., Cazzaniga, M., Lorusso, V., Latorre, A., Campanella, G., Ciccarese, M., Accettura, C., Pisconti, S., Rinaldi, A., Brunetti, C., Raffaele, M., Coltelli, L., Spazzapan, S., Fratino, L., Petrucelli, L. & 1 others, Biganzoli, L., Jun 2019, In : Oncologist. 24, 6, p. e232-e240

    Research output: Contribution to journalArticle

    Open Access
  • Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study

    Cazzaniga, M. E., Pinotti, G., Montagna, E., Amoroso, D., Berardi, R., Butera, A., Cagossi, K., Cavanna, L., Ciccarese, M., Cinieri, S., Cretella, E., De Conciliis, E., Febbraro, A., Ferraù, F., Ferzi, A., Fiorentini, G., Fontana, A., Gambaro, A. R., Garrone, O., Gebbia, V. & 52 others, Generali, D., Gianni, L., Giovanardi, F., Grassadonia, A., Leonardi, V., Marchetti, P., Melegari, E., Musolino, A., Nicolini, M., Putzu, C., Riccardi, F., Santini, D., Saracchini, S., Sarobba, M. G., Schintu, M. G., Scognamiglio, G., Spadaro, P., Taverniti, C., Toniolo, D., Tralongo, P., Turletti, A., Valenza, R., Valerio, M. R., Vici, P., Clivio, L., Torri, V., Cicchiello, F., Riva, F., Vallini, I., Mazza, M., Bonfadini, C., Bordin, E., Canicattì, M., Cappuccio, F., Collovà, E., De Angelis, C., Desorte, R., Donati, S., Drudi, G., Galanti, D., Mocerino, C., Orlando, L., Pellegrino, B., Pizzuti, L., Ridolfi, C., Rocca, A., Sarti, D., Spagnoletti, I., Tinari, N., Vandone, A., Vizzini, L. & Group, VICTOR. S., 2019, In : Breast. 48, p. 7-16 10 p.

    Research output: Contribution to journalArticle

    Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study

    Cosimo, S. D., Verde, N. L., Moretti, A., Cazzaniga, M. E., Generali, D., Bianchi, G. V., Mariani, L., Torri, V., Crippa, F., Paolini, B., Scaperrotta, G., De Santis, M. C., Nicola, M. D., Apolone, G., Gulino, A., Tripodo, C., Colombo, M. P., Folli, S. & de Braud, F., Jan 1 2019, In : PLoS One. 14, 8, e0220644.

    Research output: Contribution to journalArticle

    Open Access
  • Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity

    the CI-PeriNomS Group, Mar 1 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 111-119 9 p.

    Research output: Contribution to journalArticle